OpenAI CEO Tackles AI Concerns, BlueFocus Aims for AI Marketing Dominance, NHS Trials AI Note-Taking Tool, Lightrun Secures 70M Series B, and more...

OpenAI CEO Addresses Concerns Over ChatGPT's 'Sycophantic' Behavior and AI Manipulation RisksBlueFocus Targets Global AI Marketing Dominance with 15.55% Revenue Surge and New StrategiesUK NHS Trials AI Note-Taking Tool to Revolutionize Patient Care and Reduce BureaucracyLightrun Secures $70M Series B to Revolutionize Real-Time Code Fixing with AIGlacier Secures Funding to Revolutionize U.S. Recycling with AI Robots, Expands to SeattleTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Digital Watch Observatory